Lars B. Abrahmsen - SVP, Chief Scientific Officer at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Scientific Officer
Stock Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lars B. Abrahmsen since 7/7/2023

Holdings reported by Lars B. Abrahmsen for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 43,700 $161 K $3.68 Mar 10, 2022 Direct
Stock Option (right to Buy) 100,000 Mar 10, 2022 Direct Common Stock

Transactions reported by Lars B. Abrahmsen for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership